bms-564,929
BMS-806 (BMS 378806) |
|||
| MBS386661-100mg | MyBiosource | 100mg | 1070 EUR |
BMS-806 (BMS 378806) |
|||
| MBS386661-10mg | MyBiosource | 10mg | 245 EUR |
BMS-806 (BMS 378806) |
|||
| MBS386661-1mLinDMSO | MyBiosource | 1mL(inDMSO) | 225 EUR |
BMS-806 (BMS 378806) |
|||
| MBS386661-50mg | MyBiosource | 50mg | 615 EUR |
BMS-806 (BMS 378806) |
|||
| MBS386661-5mg | MyBiosource | 5mg | 180 EUR |
BMS-193885 |
|||
| 574340 | MedKoo Biosciences | 10.0mg | 445 EUR |
BMS-189961 |
|||
| 574341 | MedKoo Biosciences | 1.0mg | 220 EUR |
BMS-181174 |
|||
| 574452 | MedKoo Biosciences | 1.0mg | 345 EUR |
BMS-935177 |
|||
| 526843 | MedKoo Biosciences | 100.0mg | 1650 EUR |
BMS-986020 |
|||
| 526856 | MedKoo Biosciences | 10.0mg | 150 EUR |
BMS-986188 |
|||
| 527096 | MedKoo Biosciences | 10.0mg | 150 EUR |
BMS-986187 |
|||
| 527097 | MedKoo Biosciences | 10.0mg | 150 EUR |
BMS-986122 |
|||
| 531573 | MedKoo Biosciences | 5.0mg | 295 EUR |
BMS-833923 |
|||
| 9547-25 | Biovision | each | 652.8 EUR |
BMS-833923 |
|||
| 9547-5 | Biovision | each | 210 EUR |
BMS-299897 |
|||
| 9606-25 | Biovision | each | 810 EUR |
BMS-299897 |
|||
| 9606-5 | Biovision | each | 248.4 EUR |
BMS-754807 |
|||
| A1185-100 | ApexBio | 100 mg | 560 EUR |
|
Description: IGF-1R/InsR inhibitor,potent and selective |
|||
BMS-754807 |
|||
| A1185-25 | ApexBio | 25 mg | 200 EUR |
|
Description: IGF-1R/InsR inhibitor,potent and selective |
|||
BMS-754807 |
|||
| A1185-5 | ApexBio | 5 mg | 52 EUR |
|
Description: IGF-1R/InsR inhibitor,potent and selective |
|||
BMS-754807 |
|||
| A1185-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 72 EUR |
|
Description: IGF-1R/InsR inhibitor,potent and selective |
|||
BMS-599626 |
|||
| 1614-1 | Biovision | each | 255.6 EUR |
BMS-599626 |
|||
| 1614-5 | Biovision | each | 738 EUR |
BMS-911543 |
|||
| 205767 | MedKoo Biosciences | 5.0mg | 300 EUR |
BMS-906024 |
|||
| 205827 | MedKoo Biosciences | 5.0mg | 315 EUR |
BMS-794833 |
|||
| 206106 | MedKoo Biosciences | 10.0mg | 150 EUR |
BMS-986142 |
|||
| 206730 | MedKoo Biosciences | 5.0mg | 150 EUR |
BMS-986205 |
|||
| 206817 | MedKoo Biosciences | 25.0mg | 150 EUR |
BMS-986158 |
|||
| 206823 | MedKoo Biosciences | 1.0mg | 260 EUR |
BMS-777607 |
|||
| 2455-25 | Biovision | each | 679.2 EUR |
BMS-777607 |
|||
| 2455-5 | Biovision | each | 222 EUR |
BMS-303141 |
|||
| 2821-10 | Biovision | each | 248.4 EUR |
BMS-303141 |
|||
| 2821-50 | Biovision | each | 823.2 EUR |
BMS-536924 |
|||
| 200521 | MedKoo Biosciences | 10.0mg | Ask for price |
BMS-777607 |
|||
| 200527 | MedKoo Biosciences | 10.0mg | 150 EUR |
BMS-754807 |
|||
| 200534 | MedKoo Biosciences | 25.0mg | 350 EUR |
BMS-911543 |
|||
| 2630-1 | Biovision | each | 170.4 EUR |
BMS-911543 |
|||
| 2630-5 | Biovision | each | 496.8 EUR |
BMS-754807 |
|||
| 2631-1 | Biovision | each | 157.2 EUR |
BMS-754807 |
|||
| 2631-5 | Biovision | each | 444 EUR |
BMS-790052 |
|||
| 27054 | BPS Bioscience | 5 mg | 275 EUR |
|
Description: BMS-790052 is a highly selective and highly potent inhibitor of hepatitis C virus (HCV) NS5A. The mean EC50 values of BMS-790052 are 50 and 9 pM for HCV genotype 1a and 1b replicons, respectively. BMS-790052 is inactive towards a panel of 10 RNA and DNA viruses, with EC50 higher than 10 µM. |
|||
BMS-986242 |
|||
| 464050 | MedKoo Biosciences | 200.0mg | 3950 EUR |
BMS-265246 |
|||
| 401152 | MedKoo Biosciences | 5.0mg | 150 EUR |
BMS-566419 |
|||
| 406374 | MedKoo Biosciences | 10.0mg | 380 EUR |
BMS-817378 |
|||
| 407348 | MedKoo Biosciences | 50.0mg | 450 EUR |
BMS-813160 |
|||
| 407861 | MedKoo Biosciences | 5.0mg | 190 EUR |
BMS-605541 |
|||
| 407869 | MedKoo Biosciences | 10.0mg | 315 EUR |
BMS-986260 |
|||
| 408067 | MedKoo Biosciences | 10.0mg | 190 EUR |
BMS-708163 |
|||
| B1622-25 | Biovision | each | 966 EUR |
BMS-708163 |
|||
| B1622-5 | Biovision | each | 288 EUR |
BMS-582949 |
|||
| B1704-1 | Biovision | each | 222 EUR |
BMS-582949 |
|||
| B1704-5 | Biovision | each | 705.6 EUR |
BMS-986205 |
|||
| B1839-25 | Biovision | each | 966 EUR |
BMS-986205 |
|||
| B1839-5 | Biovision | each | 288 EUR |
BMS-536924 |
|||
| B1908-1 | Biovision | each | 170.4 EUR |
BMS-536924 |
|||
| B1908-5 | Biovision | each | 496.8 EUR |
BMS-919373 |
|||
| B197655 | Toronto Research Chemicals | 250mg | 7600 EUR |
|
Description: 1272353-82-8 |
|||
BMS-986158 |
|||
| B2021-1 | Biovision | each | 170.4 EUR |
BMS-986158 |
|||
| B2021-5 | Biovision | each | 496.8 EUR |
BMS-794833 |
|||
| B2055-5 | Biovision | each | 235.2 EUR |
BMS-986142 |
|||
| B2420-1 | Biovision | each | 235.2 EUR |
BMS-986142 |
|||
| B2420-5 | Biovision | each | 757.2 EUR |
BMS-303141 |
|||
| B1079-10 | ApexBio | 10 mg | 68 EUR |
|
Description: ATP-citrate lyase inhibitor,potent |
|||
BMS-303141 |
|||
| B1079-25 | ApexBio | 25 mg | 136 EUR |
|
Description: ATP-citrate lyase inhibitor,potent |
|||
BMS-303141 |
|||
| B1079-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 58 EUR |
|
Description: ATP-citrate lyase inhibitor,potent |
|||
BMS-303141 |
|||
| B1079-50 | ApexBio | 50 mg | 240 EUR |
|
Description: ATP-citrate lyase inhibitor,potent |
|||
BMS-794833 |
|||
| B1438-10 | ApexBio | 10 mg | 140 EUR |
|
Description: Met/VEGFR-2 inhibitor,potent and ATP-competitive |
|||
BMS-794833 |
|||
| B1438-5 | ApexBio | 5 mg | 79 EUR |
|
Description: Met/VEGFR-2 inhibitor,potent and ATP-competitive |
|||
BMS-794833 |
|||
| B1438-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 88 EUR |
|
Description: Met/VEGFR-2 inhibitor,potent and ATP-competitive |
|||
BMS-794833 |
|||
| B1438-50 | ApexBio | 50 mg | 540 EUR |
|
Description: Met/VEGFR-2 inhibitor,potent and ATP-competitive |
|||
BMS-794833 |
|||
| B1438-S | ApexBio | Evaluation Sample | 22 EUR |
|
Description: Met/VEGFR-2 inhibitor,potent and ATP-competitive |
|||
BMS-986020 |
|||
| B2290-25 | Biovision | each | 757.2 EUR |
BMS-986020 |
|||
| B2290-5 | Biovision | each | 235.2 EUR |
BMS-663068 |
|||
| B2299-25 | Biovision | each | 907.2 EUR |
BMS-663068 |
|||
| B2299-5 | Biovision | each | 274.8 EUR |
BMS-817378 |
|||
| B5862-10 | ApexBio | 10 mg | 373.2 EUR |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
|||
BMS-817378 |
|||
| B5862-5 | ApexBio | 5 mg | 226.8 EUR |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
|||
BMS-817378 |
|||
| B5862-50 | ApexBio | 50 mg | 999.6 EUR |
|
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
|||
BMS-265246 |
|||
| B596060 | Toronto Research Chemicals | 500mg | 12800 EUR |
|
Description: 582315-72-8 |
|||
BMS-564929 |
|||
| B596305 | Toronto Research Chemicals | 1g | 11200 EUR |
|
Description: 627530-84-1 |
|||
BMS-846372 |
|||
| B596325 | Toronto Research Chemicals | 250mg | 19000 EUR |
|
Description: 1190363-03-1 |
|||
BMS-986205 |
|||
| B596415 | Toronto Research Chemicals | 75mg | 15000 EUR |
|
Description: 1923833-60-6 |
|||
BMS-582949 |
|||
| B6187-1 | ApexBio | 1 mg | 66 EUR |
|
Description: p38 MAPK inhibitor |
|||
BMS-582949 |
|||
| B6187-25 | ApexBio | 25 mg | 502 EUR |
|
Description: p38 MAPK inhibitor |
|||
BMS-582949 |
|||
| B6187-5 | ApexBio | 5 mg | 166 EUR |
|
Description: p38 MAPK inhibitor |
|||
BMS-378806 |
|||
| B1533-10 | ApexBio | 10 mg | 194 EUR |
|
Description: Gp120/CD4 inhibitor |
|||
BMS-378806 |
|||
| B1533-100 | ApexBio | 100 mg | 864 EUR |
|
Description: Gp120/CD4 inhibitor |
|||
BMS-378806 |
|||
| B1533-5 | ApexBio | 5 mg | 106 EUR |
|
Description: Gp120/CD4 inhibitor |
|||
BMS-378806 |
|||
| B1533-5.1 | ApexBio | 10 mM (in 1mL DMSO) | 282 EUR |
|
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
|||
BMS-378806 |
|||
| B1533-50 | ApexBio | 50 mg | 600 EUR |
|
Description: Gp120/CD4 inhibitor |
|||